Study of the effect of chronic kidney disease on the incidence of cardiovascular events in a native Spanish population

被引:0
|
作者
Cancho, Barbara [1 ]
Robles, Nicolas Roberto [1 ,2 ,3 ]
Felix-Redondo, Francisco Javier [4 ]
Lozano, Luis [5 ]
Fernandez-Berges, Daniel [6 ,7 ,8 ]
机构
[1] Hosp Univ Badajoz, Badajoz, Spain
[2] Univ Salamanca, Fac Med, Catedra Riesgo Vasc, Salamanca, Spain
[3] Inst Salud Carlos III RENINRED, Red Invest Renal, Madrid, Spain
[4] Ctr Salud Villanueva Serena Norte, Villanueva Serena, Badajoz, Spain
[5] Ctr Salud Merida, Badajoz, Spain
[6] Programa Invest Enfermedades Cardiovasc, Unidad Invest Don BenitoVillanueva Serena, Villanueva Serena, Badajoz, Spain
[7] Grp Invest Multidisciplinar Extremadura, Badajoz, Spain
[8] Inst Univ Invest Biosanitaria Extremadura IN, Badajoz, Spain
来源
MEDICINA CLINICA | 2021年 / 157卷 / 12期
关键词
Chronic kidney disease; Urinary albumin excretion; Cardiovascular disease; GLOMERULAR-FILTRATION-RATE; URINARY ALBUMIN EXCRETION; RISK; PREVALENCE; OUTCOMES; SPAIN; EPIDEMIOLOGY; DYSFUNCTION; MORTALITY; DEATH;
D O I
10.1016/j.medcli.2020.10.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To evaluate the relationship between chronic kidney disease and the patient's cardiovascular risk measured through the incidence of major adverse cardiovascular events in a sample of Spanish population. Design and methods: The sample consisted of 2,668 subjects. Mean age was 50.6 +/- 14.5 years and 54.6% were female. In all, 3.5% of subjects had a glomerular filtration rate (GFR) below 60 ml/min and 4.3% a urinary albumin excretion (UAE) above 30 mg/g. GFR was estimated from serum creatinine using the CKD-EPI equation. UAE was measured in first morning urine sample as mg/g of creatinine. We examined the multivariable association between the estimated GFR and the risks of cardiovascular events and death. The median follow-up was 81 (75-89) months. Results: In CKD patients the hazard ratio (HR) was 1.36 (95% CI 0.97-1.91) (P = .079) for cardiovascu-lar events and 1.62 (95% CI 0.53-4.91) (P = .396) for cardiovascular mortality. Increased UAE was also associated with higher cardiovascular risk (HR 2.38; 95% CI 1.51-3.74; P < .001) as well as increased car-diovascular mortality (HR 4.78; 95% CI 2.50-9.11; P < .001). For patients with UAE between 30 and 300 mg/g HR for cardiovascular events was 2.09 (95% CI 1.34-3.50; P = .005) and 3.80 (95% CI 1.81-7.96; P < .001) for cardiovascular mortality. Conclusions: An independent association was found between reduced GFR and cardiovascular event inci-dence and mortality. Increased UAE showed a higher prognostic value than decreased GFR. Our findings highlight the clinical and public health importance of routinely measuring UAE. (C) 2021 Elsevier Espan tilde a, S.L.U. All rights reserved.
引用
收藏
页码:569 / 574
页数:6
相关论文
共 50 条
  • [31] Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease
    Fahrleitner-Pammer, Astrid
    Herberth, Johann
    Browning, Steven R.
    Obermayer-Pietsch, Barbara
    Wirnsberger, Gerhard
    Holzer, Herwig
    Dobnig, Harald
    Malluche, Hartmut H.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (11) : 1850 - 1858
  • [32] Thyroid function and cardiovascular events in chronic kidney disease patients
    Baris Afsar
    Mahmut Ilker Yilmaz
    Dimitrie Siriopol
    Hilmi Umut Unal
    Mutlu Saglam
    Murat Karaman
    Mustafa Gezer
    Alper Sonmez
    Tayfun Eyileten
    Ibrahim Aydin
    Salih Hamcan
    Yusuf Oguz
    Adrian Covic
    Mehmet Kanbay
    Journal of Nephrology, 2017, 30 : 235 - 242
  • [33] Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    Go, AS
    Chertow, GM
    Fan, DJ
    McCulloch, CE
    Hsu, CY
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13): : 1296 - 1305
  • [34] CHRONIC KIDNEY DISEASE AS A RISK FACTOR FOR CARDIOVASCULAR EVENTS OR MORTALITY
    Bowman, K.
    Ble, A.
    Delgado, J.
    Melzer, D.
    GERONTOLOGIST, 2015, 55 : 25 - 25
  • [35] Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease
    Weyrich, Michael
    Cremer, Sebastian
    Gerster, Martin
    Sarakpi, Tamim
    Rasper, Tina
    Zewinger, Stephen
    Patyna, Sammy R.
    Leistner, David M.
    Heine, Gunnar H.
    Wanner, Christoph
    Maerz, Winfried
    Fliser, Danilo
    Dimmeler, Stefanie
    Zeiher, Andreas M.
    Speer, Thimoteus
    CIRCULATION, 2024, 150 (10) : 746 - 757
  • [36] CARDIOVASCULAR EVENTS AND DEATH IN PEOPLE LIVING WITH CHRONIC KIDNEY DISEASE
    Cuthbertson, L.
    Cash, E.
    Prentice, L.
    Black, A.
    Burgess, J.
    Macintyre, K.
    Saunder, T.
    Kitsos, A.
    Jose, K.
    Raj, R.
    Mckercher, C. E.
    Radford, J.
    Jose, M.
    NEPHROLOGY, 2020, 25 : 46 - 46
  • [37] Loss of Y chromosome and cardiovascular events in chronic kidney disease
    Zeiher, Andreas
    CIRCULATION RESEARCH, 2024, 135
  • [38] Framingham Risk Score with Cardiovascular Events in Chronic Kidney Disease
    Chen, Szu-Chia
    Su, Ho-Ming
    Tsai, Yi-Chun
    Huang, Jiun-Chi
    Chang, Jer-Ming
    Hwang, Shang-Jyh
    Chen, Hung-Chun
    PLOS ONE, 2013, 8 (03):
  • [39] Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease
    McCausland, Finnian R.
    Singh, Ajay K.
    Solomon, Scott D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (26): : 2481 - 2485
  • [40] Cardiovascular events and death in Japanese patients with chronic kidney disease
    Tanaka, Kenichi
    Watanabe, Tsuyoshi
    Takeuchi, Ayano
    Ohashi, Yasuo
    Nitta, Kosaku
    Akizawa, Tadao
    Matsuo, Seiichi
    Imai, Enyu
    Makino, Hirofumi
    Hishida, Akira
    KIDNEY INTERNATIONAL, 2017, 91 (01) : 227 - 234